Spectral Med Inc
Spectral Medical Inc. focuses on the development and commercialization of products for the treatment of septic shock in the United States, Italy, Ireland, Russia, and internationally. The company markets Endotoxin Activity Assay, a rapid in-vitro diagnostic test for the detection of components of gram negative bacterial cell wall; and Polymyxin B-Hemoperfusion, a therapeutic hemoperfusion device … Read more
Spectral Med Inc (EDTXF) - Net Assets
Latest net assets as of September 2025: $-68.66 Million USD
Based on the latest financial reports, Spectral Med Inc (EDTXF) has net assets worth $-68.66 Million USD as of September 2025.
Net assets (also known as shareholders' equity or book value) represent the difference between a company's total assets ($8.12 Million) and total liabilities ($76.79 Million). This figure indicates the residual interest in the assets after deducting liabilities, essentially showing what would remain for shareholders if all assets were liquidated and all debts paid off.
Key Net Assets Metrics
| Metric | Value |
|---|---|
| Current Net Assets | $-68.66 Million |
| % of Total Assets | -845.1% |
| Annual Growth Rate | N/A |
| 5-Year Change | N/A |
| 10-Year Change | -606.99% |
| Growth Volatility | 322.33 |
Spectral Med Inc - Net Assets Trend (1992–2024)
This chart illustrates how Spectral Med Inc's net assets have evolved over time, based on quarterly financial data. Explore and compare other companies by net assets.
Annual Net Assets for Spectral Med Inc (1992–2024)
The table below shows the annual net assets of Spectral Med Inc from 1992 to 2024.
| Year | Net Assets | Change |
|---|---|---|
| 2024-12-31 | $-27.55 Million | -66.45% |
| 2023-12-31 | $-16.55 Million | -555.93% |
| 2022-12-31 | $-2.52 Million | -161.79% |
| 2021-12-31 | $4.08 Million | +710.31% |
| 2020-12-31 | $-669.00K | -129.60% |
| 2019-12-31 | $2.26 Million | -64.52% |
| 2018-12-31 | $6.37 Million | +124.69% |
| 2017-12-31 | $2.83 Million | -51.31% |
| 2016-12-31 | $5.82 Million | +7.16% |
| 2015-12-31 | $5.43 Million | -38.40% |
| 2014-12-31 | $8.82 Million | +54.85% |
| 2013-12-31 | $5.70 Million | -46.13% |
| 2012-12-31 | $10.57 Million | -44.17% |
| 2011-12-31 | $18.94 Million | +20.27% |
| 2010-12-31 | $15.75 Million | +1053.63% |
| 2009-12-31 | $1.36 Million | -66.30% |
| 2008-12-31 | $4.05 Million | -25.57% |
| 2007-12-31 | $5.44 Million | -22.11% |
| 2006-12-31 | $6.99 Million | +1006.24% |
| 2005-12-31 | $631.69K | +62.81% |
| 2004-12-31 | $388.00K | -94.66% |
| 2003-12-31 | $7.27 Million | -29.92% |
| 2002-12-31 | $10.37 Million | +87.39% |
| 2001-12-31 | $5.53 Million | -51.55% |
| 2000-12-31 | $11.42 Million | +65.60% |
| 1999-12-31 | $6.90 Million | -29.61% |
| 1998-12-31 | $9.80 Million | -44.32% |
| 1997-12-31 | $17.60 Million | -54.99% |
| 1996-12-31 | $39.10 Million | +30.33% |
| 1995-12-31 | $30.00 Million | -23.66% |
| 1994-12-31 | $39.30 Million | -5.76% |
| 1993-12-31 | $41.70 Million | +997.37% |
| 1992-12-31 | $3.80 Million | -- |
Equity Component Analysis
This analysis shows how different components contribute to Spectral Med Inc's total equity over time. Equity components include common stock, retained earnings, additional paid-in capital, and other elements.
Equity Composition Insights
- Retained earnings have decreased by 13723900000.0% over the analyzed period, potentially due to dividend distributions or operating losses.
Current Equity Component Breakdown (December 2024)
| Component | Amount | Percentage |
|---|---|---|
| Common Stock | $90.57 Million | % |
| Other Comprehensive Income | $12.58 Million | % |
| Other Components | $10.15 Million | % |
| Total Equity | $-27.55 Million | 100.00% |
Spectral Med Inc Competitors by Market Cap
The table below lists competitors of Spectral Med Inc ranked by their market capitalization.
| Company | Market Cap |
|---|---|
|
ITAB Shop Concept AB ser. B
ST:ITAB
|
$142.82 Million |
|
Beyond Oil Ltd.
PINK:BEOLF
|
$142.84 Million |
|
Jouder Precision Industry Kunshan Co Ltd
SHE:300549
|
$142.89 Million |
|
Xinjiang East Universe Group Gas Co Ltd
SHG:603706
|
$142.93 Million |
|
Healwell AI Inc.
OTCQX:HWAIF
|
$142.74 Million |
|
Franbo Lines
TWO:2641
|
$142.71 Million |
|
ALT5 Sigma Corporation
NASDAQ:ALTS
|
$142.67 Million |
|
Fuji Pharma Co. Ltd
F:FUP
|
$142.64 Million |
Equity Growth Attribution
This analysis shows how different factors contributed to changes in Spectral Med Inc's equity between the two most recent reporting periods.
Equity Growth Insights
- From 2023 to 2024, total equity changed from -16,549,000 to -27,545,000, a change of -10,996,000.
- Net loss of 15,402,000 reduced equity.
- Other comprehensive income decreased equity by 331,999.
- Other factors increased equity by 4,737,999.
Equity Change Factors (2023 to 2024)
| Factor | Impact | Contribution |
|---|---|---|
| Net Income | $-15.40 Million | -55.92% |
| Other Comprehensive Income | $-332.00K | -1.21% |
| Other Changes | $4.74 Million | +17.2% |
| Total Change | $- | % |
Book Value vs Market Value Analysis
This analysis compares Spectral Med Inc's book value (net assets) with its market value over time. The relationship between these values can provide insights into investor sentiment and company valuation.
Valuation Insights
Historical Price-to-Book Ratios
| Date | Book Value per Share | Market Price | P/B Ratio |
|---|---|---|---|
| 1992-12-31 | $0.94 | $0.50 | x |
| 1993-12-31 | $7.85 | $0.50 | x |
| 1994-12-31 | $5.85 | $0.50 | x |
| 1995-12-31 | $4.20 | $0.50 | x |
| 1996-12-31 | $4.74 | $0.50 | x |
| 1997-12-31 | $1.81 | $0.50 | x |
| 1998-12-31 | $1.00 | $0.50 | x |
| 1999-12-31 | $0.70 | $0.50 | x |
| 2000-12-31 | $1.05 | $0.50 | x |
| 2001-12-31 | $0.41 | $0.50 | x |
| 2002-12-31 | $0.72 | $0.50 | x |
| 2003-12-31 | $0.45 | $0.50 | x |
| 2004-12-31 | $0.02 | $0.50 | x |
| 2006-12-31 | $0.31 | $0.50 | x |
| 2007-12-31 | $0.23 | $0.50 | x |
| 2008-12-31 | $0.17 | $0.50 | x |
| 2009-12-31 | $0.06 | $0.50 | x |
| 2010-12-31 | $0.23 | $0.50 | x |
| 2011-12-31 | $0.21 | $0.50 | x |
| 2012-12-31 | $0.09 | $0.50 | x |
| 2013-12-31 | $0.04 | $0.50 | x |
| 2014-12-31 | $0.06 | $0.50 | x |
| 2015-12-31 | $0.03 | $0.50 | x |
| 2016-12-31 | $0.03 | $0.50 | x |
| 2017-12-31 | $0.01 | $0.50 | x |
| 2018-12-31 | $0.03 | $0.50 | x |
| 2019-12-31 | $0.01 | $0.50 | x |
| 2020-12-31 | $0.00 | $0.50 | x |
| 2021-12-31 | $0.02 | $0.50 | x |
| 2022-12-31 | $-0.01 | $0.50 | x |
| 2023-12-31 | $-0.06 | $0.50 | x |
| 2024-12-31 | $-0.10 | $0.50 | x |
Capital Efficiency Dashboard
This dashboard shows how efficiently Spectral Med Inc utilizes its equity to generate returns, including Return on Equity (ROE) and its components based on the DuPont analysis framework.
Capital Efficiency Insights
- Current Return on Equity (ROE): 0.00%
- The company may be facing challenges in efficiently utilizing shareholder equity.
- DuPont Analysis Breakdown:
- • Net Profit Margin: -673.75%
- • Asset Turnover: 0.43x
- • Equity Multiplier: 0.00x
- Recent ROE (0.00%) is above the historical average (-128.39%), indicating improving capital efficiency.
Historical Capital Efficiency Metrics
| Year | Return on Equity | Net Profit Margin | Asset Turnover | Equity Multiplier | Economic Value Added |
|---|---|---|---|---|---|
| 1992 | -84.21% | -3200.00% | 0.02x | 1.18x | $-3.58 Million |
| 1993 | -8.15% | -1700.00% | 0.00x | 1.03x | $-7.57 Million |
| 1994 | -22.90% | -1800.00% | 0.01x | 1.04x | $-12.93 Million |
| 1995 | -46.67% | -2333.33% | 0.02x | 1.06x | $-17.00 Million |
| 1996 | -34.78% | -906.67% | 0.04x | 1.09x | $-17.51 Million |
| 1997 | -73.30% | -243.40% | 0.22x | 1.39x | $-14.66 Million |
| 1998 | -105.10% | -98.10% | 0.65x | 1.64x | $-11.28 Million |
| 1999 | -110.18% | -77.55% | 0.70x | 2.03x | $-8.29 Million |
| 2000 | -46.99% | -48.92% | 0.52x | 1.83x | $-6.51 Million |
| 2001 | -97.02% | -40.55% | 0.78x | 3.07x | $-5.92 Million |
| 2002 | -42.75% | -30.60% | 0.70x | 1.99x | $-5.47 Million |
| 2003 | -29.67% | -18.35% | 0.68x | 2.39x | $-2.88 Million |
| 2004 | -1896.39% | -73.57% | 0.88x | 29.30x | $-7.40 Million |
| 2005 | 0.00% | 0.00% | 0.63x | 15.66x | $-63.17K |
| 2006 | 53.38% | 171.97% | 0.23x | 1.34x | $3.03 Million |
| 2007 | -30.61% | -55.66% | 0.38x | 1.47x | $-2.21 Million |
| 2008 | -37.08% | -49.88% | 0.42x | 1.75x | $-1.91 Million |
| 2009 | -202.49% | -84.19% | 0.65x | 3.69x | $-2.90 Million |
| 2010 | -41.70% | -232.79% | 0.16x | 1.10x | $-8.14 Million |
| 2011 | -35.45% | -264.40% | 0.12x | 1.09x | $-8.61 Million |
| 2012 | -80.79% | -329.97% | 0.21x | 1.19x | $-9.60 Million |
| 2013 | -198.51% | -423.17% | 0.28x | 1.66x | $-11.88 Million |
| 2014 | -107.62% | -320.24% | 0.25x | 1.34x | $-10.37 Million |
| 2015 | -175.30% | -308.32% | 0.37x | 1.56x | $-10.07 Million |
| 2016 | -174.32% | -286.29% | 0.50x | 1.22x | $-10.73 Million |
| 2017 | -138.94% | -103.49% | 1.10x | 1.23x | $-4.22 Million |
| 2018 | -39.07% | -64.82% | 0.55x | 1.10x | $-3.13 Million |
| 2019 | -215.04% | -169.46% | 0.72x | 1.77x | $-5.09 Million |
| 2020 | 0.00% | -433.03% | 0.26x | 0.00x | $-9.03 Million |
| 2021 | -215.16% | -428.12% | 0.18x | 2.83x | $-9.19 Million |
| 2022 | 0.00% | -674.87% | 0.14x | 0.00x | $-11.00 Million |
| 2023 | 0.00% | -980.10% | 0.31x | 0.00x | $-14.01 Million |
| 2024 | 0.00% | -673.75% | 0.43x | 0.00x | $-12.65 Million |
Industry Comparison
This section compares Spectral Med Inc's net assets metrics with peer companies in the Diagnostics & Research industry.
Industry Context
- Industry: Diagnostics & Research
- Average net assets among peers: $914,015,556
- Average return on equity (ROE) among peers: -22.24%
Peer Company Comparison
| Company | Net Assets | Return on Equity | Debt-to-Equity | Market Cap |
|---|---|---|---|---|
| Spectral Med Inc (EDTXF) | $-68.66 Million | -84.21% | N/A | $142.75 Million |
| Agilent Technologies Inc (A) | $4.08 Billion | 3.46% | 0.65x | $31.80 Billion |
| Amer Bio Medica (ABMC) | $3.38 Million | -26.64% | 1.08x | $3.55K |
| ADCNF (ADCNF) | $1.77 Billion | 2.65% | 1.64x | $172.01 Million |
| Advanced Biomed Inc. Common Stock (ADVB) | $3.48 Billion | 0.00% | 0.87x | $1.68 Million |
| ANGLE plc (ANPCF) | $18.44 Million | -77.14% | 0.38x | $34.42 Million |
| SeqLL Inc. (ATLN) | $8.18 Million | -45.26% | 0.31x | $35.63K |
| Avricore Health Inc (AVCRF) | $2.20 Million | -79.50% | 0.04x | $3.22 Million |
| Aspira Womens Health Inc (AWH) | $-11.46 Million | 0.00% | 0.00x | $664.47K |
| Biodesix Inc (BDSX) | $-198.03 Million | 0.00% | 0.00x | $50.38 Million |
| bioAffinity Technologies, Inc. (BIAF) | $-15.79 Million | 0.00% | 0.00x | $5.08 Million |